BMJ Best Practice

参考文献

关键文献

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.

Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006;26:326-41.

Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008;19:255-262.

参考文章

1.  Joshi D, Dhawan A, Baker AJ, et al. An atypical presentation of cystic fibrosis: a case report. J Med Case Reports. 2008;12;2:201.

2.  Lee WB, Hamilton SM, Harris JD, et al. Ocular complications of hypovitaminosis A after bariatric surgery. Ophthalmology. 2005;112:1031-1034.

3.  Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.

4.  Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006;26:326-41.

5.  Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol. 2006;21:135-141.

6.  Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008;19:255-262.

7.  Jayaram H, Downes SM. Midlife diagnosis of Refsum disease in siblings with retinitis pigmentosa--the footprint is the clue: a case report. J Med Case Reports. 2008;2:80.

8.  McCauley ME, van den Broek N, Dou L, et al. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database Syst Rev. 2015;(10):CD008666.

9.  Sommer A. Vitamin A deficiency and clinical disease: an historical overview. J Nutr. 2008;138:1835-1839.

10.  Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun. 1989;161:825-829.

11.  Potter MJ, Thirkill CE, Dam OM, et al. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106:2121-2125.

12.  Javadzadeh A, Gharabaghi D. Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report. J Med Case Reports. 2007;12;1:27.

13.  Renner AB, Kellner U, Cropp E, et al. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology. 2006;113:2066.e1-10.

14.  Radhika MS, Bhaskaram P, Balakrishna N, et al. Effects of Vitamin A deficiency during pregnancy on maternal and child health. BJOG. 2002;109:689-93.

15.  Mayo-Wilson E, Imdad A, Herzer K, et al. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011;343:5094

16.  Alio JL, Pinero D, Muftuoglu O. Corneal wavefront-guided retreatments for significant night vision symptoms after myopic laser refractive surgery. Am J Ophthalmol. 2008;145:65-74.

17.  McCulloch DL , Marmor MF, Brigell MG, et al. ISCEV standard for full-field clinical electroretinography (2015 update). Documenta Ophthalmologica. 2015;130:1-12.

18.  Tanumihardjo SA. Assessing vitamin A status: past, present and future. J Nutr. 2004;134:290S-293S.

19.  Charman WN. Night myopia and driving. Ophthalmic Physiol Opt. 1996;16:474-485.

20.  Owsley C, Jackson GR, White M, et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.

21.  Berson EL, Rosner B, Sandberg MA, et al. Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:1456-9.

22.  Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol. 2010;128:493-495.

23.  Welsh BM, Smith AL, Elder JE, et al. Night blindness precipated by isotretinoin in the setting of hypovitaminosis A. Australas J Dermatol. 1999;40:208-210.

24.  Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.

25.  Bainbridge JW, Ali RR. Success in sight: the eyes have it! Ocular gene therapy trials for LCA look promising. Gene Ther. 2008;15:1191-1192.

26.  MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014;383:1129-1137.

27.  Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004;122:1297-1305.

28.  Hoffman DR, Locke KG, Wheaton DH, et al. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol. 2004;137:704-718.

29.  Berson EL, Rosner B, Sandberg MA, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol. 2004;122:1306-1314.

使用此内容应接受我们的免责声明